Jane Street’s Pacira BioSciences PCRX Stock Holding History

Jane Street’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52,800	Closed	-$1.26M	–	11519
2025 Q2	$1.26M	Sell	52,800 -9,700	-16%	-$245K	﹤0.01%	5190
2025 Q1	$1.55M	Buy	+62,500	New	+$1.5M	﹤0.01%	4785
2023 Q3	–	Sell	-40,000	Closed	-$1.6M	–	9178
2023 Q2	$1.6M	Sell	40,000 -200	-0.5%	-$8.27K	﹤0.01%	4495
2023 Q1	$1.64M	Buy	40,200 +4,200	+12%	+$167K	﹤0.01%	4161
2022 Q4	$1.39M	Buy	36,000 +20,100	+126%	+$978K	﹤0.01%	4453
2022 Q3	$846K	Sell	15,900 -15,800	-50%	-$879K	﹤0.01%	5721
2022 Q2	$1.85M	Sell	31,700 -17,600	-36%	-$1.15M	﹤0.01%	4317
2022 Q1	$3.76M	Buy	49,300 +37,300	+311%	+$2.49M	﹤0.01%	3524
2021 Q4	$722K	Buy	12,000 +6,100	+103%	+$336K	﹤0.01%	6577
2021 Q3	$330K	Sell	5,900 -7,800	-57%	-$450K	﹤0.01%	8003
2021 Q2	$831K	Buy	+13,700	New	+$867K	﹤0.01%	6228
2021 Q1	–	Sell	-5,600	Closed	-$335K	–	9460
2020 Q4	$335K	Buy	+5,600	New	+$328K	﹤0.01%	6262
2019 Q4	–	Sell	-8,000	Closed	-$305K	–	5560
2019 Q3	$305K	Buy	+8,000	New	+$319K	﹤0.01%	4169
2018 Q4	–	Sell	-16,400	Closed	-$806K	–	5498
2018 Q3	$806K	Sell	16,400 -500	-3%	-$21.6K	﹤0.01%	3035
2018 Q2	$542K	Buy	+16,900	New	+$583K	﹤0.01%	3505
2017 Q1	–	Sell	-10,000	Closed	-$323K	–	4544
2016 Q4	$323K	Hold	10,000	–	–	﹤0.01%	3287
2016 Q3	$342K	Buy	+10,000	New	+$392K	﹤0.01%	3167

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's PCRX Position: Q1 2026 in Review

Jane Street reduced its Pacira BioSciences (PCRX) stake by 64% in Q1 2026, selling an estimated $5.46M and leaving 140,247 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Jane Street first reported a position in PCRX in Q1 2014 and has held it in 38 quarters since. The position peaked at $9.99M in Q4 2025. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

Jane Street held 140,247 shares of Pacira BioSciences worth $3.17M as of Q1 2026.
Jane Street sold 245,737 Pacira BioSciences shares in Q1 2026, an estimated $5.46M.
Pacira BioSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4249 holding.
Jane Street first reported a position in Pacira BioSciences in Q1 2014 and has held it in 38 quarters since.
Jane Street's Pacira BioSciences position peaked at $9.99M in Q4 2025.
241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.